Manitoba getting 1,100 doses of newly approved COVID-19 antiviral treatment
Manitoba will be getting 1,100 doses of the Pfizer COVID-19 antiviral treatment called Paxlovid.
A tweet from the Manitoba Government account on Monday said this is an initial allotment and more doses have been requested.
On Monday, Health Canada announced the approval of the drug, which is the first COVID-19 therapy that can be taken at home.
Dr. Supriya Sharma, the chief medical adviser of Health Canada, said the treatment consists of two drugs that are taken together twice per day, for five days. It is only for use after the diagnosis of COVID-19 and must be given within five days of the start of symptoms.
She added the studies submitted by Pfizer for Health Canada to review showed an effectiveness at preventing severe outcomes like hospitalization and death caused by COVID-19 by close to 90 per cent when taken within three days of symptoms showing up. The effectiveness is reduced slightly when taken five days after symptom onset to 85 per cent.
“I’ve never really liked the term game changer, but this is a really important tool that I think will provide some relief to hospitals,” said Dr. Philippe Lagacé-Wiens, a medical microbiologist at St. Boniface Hospital. “But there are a lot of warnings and caveats that come with that.”
Lagacé-Wiens said because initial supply is so limited, the impact won’t be huge on hospitals. He said it is also not a replacement for vaccination. He said the province needs to get to the point where the drug is widely available and easy to access through community pharmacies.
“At that point, for the high-risk people, it probably will make a major difference," he said. "But until we get to a really good supply chain and a testing system that works, we’re not going to see a huge difference. But it’s still really good news if you think about it.”
Lagacé-Wiens also said that because a confirmed positive test is needed to get Paxlovid, testing may need to be prioritized for people at higher risk of hospitalization and death since getting the drug early is so important.
“So this is really a great tool, but it has to be applied to the community setting in mild to moderate COVID-19 to reduce hospitalizations,” he said. “We really need to have excellent access to testing to be able to identify those people who are going to benefit from it, the ones with those risk factors we have been hearing over and over again in the pandemic because those are the ones who will benefit the most.”
Lagacé-Wiens said these populations may include people over 60, those with diabetes or lung disease or who are overweight. He also said this treatment is not approved for everyone, as children and pregnant women are not eligible. Paxlovid also has many medications that it interacts with, like birth control to antidepressants and more.
There is no word on when the first shipment of Paxlovid will arrive in Manitoba or how it will be distributed.
CTVNews.ca Top Stories
Couple randomly attacked, 1 stabbed, by group of teens in Toronto, police say
A man has been transported to hospital after police say he was stabbed in a random attack carried out by a group of teens in Toronto on Friday night.
'My family doctor just fired me': Ontario patients frustrated with de-rostering
Dozens of Ontarians are expressing frustration in the province’s health-care system after their family doctors either dropped them as patients or threatened to after they sought urgent care elsewhere.
Balancing act: Canadian North’s first Inuk CEO juggles Arctic airline challenges
With carriers' flight volumes above the 60th parallel hovering below pre-pandemic levels, Canadian North’s first Inuk CEO now bears the task of balancing those financial and logistical challenges with the needs of communities for which she feels a deep affinity.
Sherpa guide Kami Rita scales Mount Everest for 29th time, extending his own record again
One of greatest climbing guides on Mount Everest has scaled the world's highest peak for the 29th time, extending his own record for most times to the summit, expedition organizers said Sunday.
Feds 'committed to doing more,' but minister offers no timeline for Canadian Disability Benefit boost
Amid significant criticism from advocates, Diversity, Inclusion and Persons with Disabilities Minister Kamal Khera is defending her government's long-promised, newly unveiled Canada Disability Benefit, calling the funds an "initial step," but without laying out a timeline for future expansion of the program.
RCMP boss expresses desire for new law to deal with threats against politicians
RCMP commissioner Mike Duheme says he wants the government to look at drafting a new law that would make it easier for police to pursue charges against people who threaten elected officials.
4th Indian national arrested, charged with murder of Hardeep Singh Nijjar
Homicide investigators in B.C. say murder charges have been laid against a fourth Indian national in connection to the killing of Sikh activist Hardeep Singh Nijjar outside a Surrey gurdwara last year.
In progressive Argentina, the 2SLGBTQ+ community says President Milei has turned back the clock
Past left-leaning presidents who enacted some of the most socially liberal policies on the continent have given way to a self-proclaimed "anarcho-capitalist" whose fiery appraisals of social justice and efforts to dismantle diversity and equity programs have made him into a global far-right icon.
Millions of Canadians have been exposed to potentially toxic chemicals, and they're not going anywhere
For decades, North Bay, Ontario's water supply has harboured chemicals associated with liver and developmental issues, cancer and complications with pregnancy. It's far from the only city with that problem.